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ABSTRACT 
Advisors: Dr. Kathleen Hughes and Dr. Lauren King 
We studied the effects of ethynodiol diacetate on the viability of hydrogen 
peroxide stressed glial cells. We wanted to determine the extent in which varying concentration of 
ethynodiol diacetate affect cell viability of cultured glial cells from hydrogen peroxide toxicity. 
Based on previous studies, we predicted that the viability of hydrogen peroxide-stressed cells will 
increase with the presence of the progesterone, ethynodiol diacetate, and that cell viability will 
increase with increasing concentration of ethynodiol diacetate. Glial cells of 1x10° cells/well were 
introduced into a 96-well plate and allowed to grow for 24 hours in an incubator at 37°C and 5% 
COs. Cells were treated with 0 nM (control), 10 nM, 100 nM, 1 uM, 10 uM ethynodiol diacetate 
in doublets, with half of the cells being stressed with hydrogen peroxide. Data were analyzed 
using a 2-way ANOVA and a Tukey’s post hoc test with a p-value of less than 0.05 being 
significant. Viability did not differ significantly between stressed and unstressed cells (2-way 
ANOVA, Fo30=1.673, P=0.211) or between cells receiving varying concentrations of ethynodiol 
diacetate (2-way ANOVA, Fo30=0.638 P=0.641). The results illustrate that ethynodiol diacetate, 
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The Involvement of Progesterone in Glial Cell Viability 
Background 
Hormonal birth control is a form of female contraception. Around sixty percent of 
women who utilize contraception currently use a non-permanent method, such as hormonal birth 
control (Daughery et al. 2014). Common hormonal methods include the birth control pill, patch, 
and vaginal ring (Daughery etal. and Jones et al., 2014, 2012) and usually contain varying 
amounts of steroid hormones including estrogens and progesterones. When consumed, estrogen 
and progesterone send a signal to the brain which causes a range of effects within the body 
including preventing ovulation, stopping production of the luteinizing hormone (LH), and 
stopping the pituitary gland from secreting the follicle-stimulating hormone (FSH) (Nichols, 
2018). One role of progesterone and estrogen is assisting in the prevention of the secretion of 
gonadotropins (FSH and LH) through a negative feedback mechanism (Shaw et al., 2010). 
Progesterone is derived from the placenta and/or the corpus luteum and has been shown 
to play an essential role in the stimulation of the uterus in preparation for pregnancy (Siiteri et 
al., 1977). It prevents ovulation and thickens the cervical mucus. Some adverse side effects 
caused by hormonal birth control include weight gain, changes in or the absence of a menstrual 
cycle, mood changes, and the worsening of migraines. With high levels of progesterone 
specifically, side effects include stomach problems, premenstrual syndrome (PMS)-like 
symptoms, irregular bleeding, breast discomfort or enlargement, and depression (Childs, 2018). 
The progesterone of interest in my study is ethynodiol diacetate. This progesterone is 
used to help prevent pregnancy by thickening the mucus within the vagina, which in turn  
prevents the sperm from penetrating the egg. Ethynodiol diacetate is a synthetic form of the 
naturally-occurring female sex hormone, progesterone (Briggs, 1975). Ethynodiol diacetate has a 
molecular weight of 384.5 g/mol and a chemical formula of C24H3,04. During the menstrual 
cycle an ovum is released from the ovary through a process known as ovulation. Following 
ovulation, the follicle that released the ovum becomes known as the corpus luteum. The corpus 
luteum produces progesterone which prevents the further release of eggs. Progesterone also 
prepares the lining of the uterus for possible pregnancies that may occur. When pregnancy 
occurs the progesterone levels remain high, and if no pregnancy occurs the levels drop resulting 
in a menstrual period. Ethynodiol diacetate prevents the release of additional ova from the 
ovaries, thus preventing pregnancy (Briggs, 1975). Progesterone affects brain physiology 
through three principle mechanisms: regulation of gene expression, modulation of 
neurotransmitter systems, and activation of signaling cascades (Brinton, D.R., et al., 2008). 
The mechanism of ethynodiol diacetate involves binding to progesterone and estrogen receptors. 
Cells expressing these receptors are found in the female reproductive tract, mammary gland, the 
hypothalamus, and the pituitary. Upon binding to the receptor, the ethynodiol diacetate will slow 
the frequency of the release of gonadotropin releasing hormone (GnHR) from the hypothalamus 
and slow the preovulatory luteinizing hormone (LH) surge (Briggs, 1975). Ethynodiol diacetate 
is a first-generation progesterone of average progestational activity. It has minor estrogenic 
effects and little androgenic activity (Progestin, 2018). Ethynodiol diacetate is a derivative of 
norethindrone, another type of progesterone. 
Astrocytes are a form of glial cells, which are predominantly found in the spinal cord and 
brain. These cells play a role in the formation of the blood-brain barrier, as well as serving as 
supportive cells for neurons. One function to note is that the astrocytes within the hypothalamus  
play a role in the central nervous system through the regulation of hormones, particularly female 
hormones (Micevych, et al., 2010). When ovulation occurs, the hypothalamus releases the 
gonadotropin releasing hormone (GnRH); this in turn triggers an increase in luteinizing hormone 
(LH) which triggers ovulation (Micevych et al., 2010) 
Recent studies have illustrated that progesterone plays a role in multiple non-reproductive 
functions in the central nervous system. These functions include the regulation of mood, 
cognition, mitochondrial function, neurogenesis and regeneration, myelination, and recovery 
from traumatic brain injury (Brinton et al., 2008). One study indicated that when progesterone 
was delivered to a patient after a brain injury, it caused a decrease in the cytotoxic responses as 
well as promoting functional recovery (Grossman, et al., 2004). Brain injuries create an 
inflammatory response by disturbing the blood brain barrier, which in turn causes edema and the 
permeation of inflammatory cells (Carlos et al., 1997). Progesterone also plays a role in 
diminishing neurological abnormalities after ischemia (Chen et al., 1999) and spinal cord injuries 
(Thomas et al., 1999), as well as the reduction of neuronal cell death (Cervantes et al., 2001). 
Hydrogen peroxide is a byproduct of respiration that, when in excessive quantities, can 
lead to cellular damage caused by oxidative stress. One study showed that hydrogen peroxide 
alters astrocyte membrane and cytoskeleton through damaging lipids, proteins, DNA, and 
through signaling molecules which cause the intracellular pathways to cause apoptosis (Choi et 
al., 2007). 
Despite advances in hormonal knowledge, not much is known about the effects 
progesterones have on the viability of astrocytes directly. Therefore, the goal of this study was to 
determine the effect progesterones have on the viability of hydrogen peroxide-stressed 
astrocytes. I hypothesized that the viability of hydrogen peroxide-stressed cells will increase with  
the presence of the progesterone, ethynodiol diacetate, and that as the concentration of 





The cell line used in this study were 1321N1, which were cultured human glioma cells 
with astrocyte-like properties (Sigma Aldrich). The cells were plated in a T-75 flask with 10 ml 
media, which consisted of Dulbecco's Modified Eagle's Medium supplemented with 10% fetal 
bovine serum and 1% penicillin/streptomycin. The media in the well plate was replaced every 
two to three days. The astrocytes were stored and incubated at 37°C with 5% supplemented CO». 
Once the cells became roughly 70-80% confluent in the flask, the existing media was 
removed and a 5 mL solution containing 0.53 mM EDTA and 25% trypsin was added to rinse the 
flask. The trypsin-EDTA solution helped remove the adherent cells from the flask’s surface. 
Once the cells were removed from the surface, the suspension was placed into a tube and 
centrifuged at 3000 x rpm for 3 minutes in order to pellet the cells. The supernatant containing 
trypsin was then removed and discarded, leaving behind the cell pellet which was resuspended in 
5 mL fresh media. This solution was then plated into a 96-well plate. Each well contained 200 
uL of media with a concentration of about 1x10° cells/mL (Grimes and Hughes, 2015). An 
automated BioRad cell counter was used in order to determine the concentration of cells in the 
wells. A solution of 100 pL of prepared astrocytes with an equal amount of trypan blue solution 
was prepared in one of the wells in the 96-well plate, which allowed for the determination of 
total and live cell count. A 10 pL. amount of the trypan blue and glial cell solution was added to 
the slide using a micropipette, which was then inserted into the counter where the live and total 
counts were determined. The number of cells counted was used to help calculate the amount of 
cell suspension and media needed to dilute the concentration to 1x10° cells/mL. Once the volume 
of cell suspension was calculated, it was then subtracted from the total amount of media that 
would be added into the cell suspension. A 200 pL cell and media solution was then added to  
each well and then placed back into the incubator. After these steps, treatment began the 
following day. 
Treatment of Astrocytes 
To test the effects of progesterone on glial cell viability, cultures treated with varying 
concentrations of ethynodiol diacetate (0 nM (control), 10 nM, 100 nM, 1 pM, 10 uM) were 
tested for viability. The ethynodiol diacetate was diluted to the appropriate concentration using 
phosphate buffered saline. The independent variables measured were ethynodiol diacetate 
treatment (at varying concentrations) and whether or not the cells were stressed with hydrogen 
peroxide. The control wells received phosphate buffered saline in volumes equal to that of the 
treatments. The cells were incubated at 37°C for one hour. Half of the wells were then treated 
with 5 pL of a 40 mM hydrogen peroxide solution for one hour. Following stress treatment, 
media was replaced in each well with 200 pL of fresh media supplemented with the appropriate 
ethynodiol diacetate concentration. Viability was then measured after incubating for 24 hours. 
Three trials were completed with the above steps. The 96-well plate used is diagrammed below. 
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Figure 1. The 96-well plate treatment diagram. The cells in rows A and B were first treated with the progesterone, 
Ethynodiol diacetate with the concentrations, 0 uM, 10 uM, 1 pM, 1 nM, and 10 nM and 100 nM, in wells 0, 2, 4, 6, 
8, and 10, respectively. All the cells in row A were stressed with 5 pL. of a 40 mM hydrogen peroxide solution, with 
all the cells in row C receiving no hydrogen peroxide. After one hour hydrogen peroxide was added and the cells 
were stressed for an hour. The solutions were then changed and replaced with 200 pL of media and the respective 
ethynodiol diacetate concentrations. Ethynodiol diacetate (P): Hydrogen Peroxide (H,0,): with (-) and (+) indicating 
the presence or absence of the variable. 
   
MTT Cell Proliferation Assay 
Following treatment, cell viability was assessed using the MTT Cell Proliferation Assay 
from Sigma Aldrich. This was done by removing 100 pl of the media and adding 10 pl of the 
MTT reagent to each well, followed by incubation at 37°C for three hours. One 100 pl of media 
containing no cells was added to a well to serve as a blank for comparison. Once the precipitate 
formed, 100 pl of the MTT solubilization solution was then added to the wells, and the 
absorbance was taken at 570 nm. A high absorbance indicated a high cell proliferation. 
Analysis of data 
To evaluate the 3 trials performed and to determine statistical significance between the 
two treatments, a 2-way Analysis of Variance (ANOVA) was used with a p-value of significance 






Absorbance values were obtained from the MTT Assay. From the MTT assay results, a 
ratio was determined between the treated cells and the control by subtracting the absorbance of 
the blank and then dividing by the control; the results were then averaged and plotted. Viability 
did not differ significantly between stressed and unstressed cells (2-way ANOVA, F930=1.673, 
P=0.211) or between cells receiving varying concentrations of ethynodiol diacetate (2-way 
ANOVA, F930=0.638 P=0.641). This is seen in Figure 1, which compares the results of the 
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Figure 1. Comparison of glial cell viability (+/- 1 S.D) for cells treated with 0 uM, 0.01 uM, 0.1 
uM, 1 pM, and 10 pM Ethynodiol diacetate that were either stressed with 5 pLfof a 40mM hydrogen 
peroxide solution or unstressed. Results were not significant between the stressed and unstressed data 
(2-way ANOVA, F , =1.673, P=0.211) and between the varying concentration of Ethynodiol diacetate 
(2-way ANOVA, F,  =0.638 P=0.641). 
The absorbance values compared to control are reported for each concentration and 
between stressed and unstressed are listed as average ratios (+/- standard error). The average 
ratio of the cells treated with 0 pM ethynodiol diacetate and stressed with hydrogen peroxide was 
0.797 (+/- 0.1517). The average absorbance ratio of the cells treated with 0.01 uM ethynodiol 
diacetate and stressed with hydrogen peroxide was 0.185 (+/- 0.1261) and unstressed was 1.014 
(+/- 0.4270). The average absorbance ratio of the cells treated with 0.1 uM ethynodiol diacetate 
and stressed with hydrogen peroxide was 0.8486 (+/- 0.2025) and unstressed was 0.3818 (+/- 
0.0320). The average absorbance ratio of the cells treated with 1 pM ethynodiol diacetate and  
13 
stressed with hydrogen peroxide was 0.4167 (+/- 0.2140) and unstressed was 0.8378 (+/-0.3408). 
The average absorbance ratio of the cells treated with 10 uM ethynodiol diacetate and stressed 






Treatment with ethynodiol diacetate and with hydrogen peroxide showed no significant 
difference in glial cell viability when compared to the unstressed control. The results did not 
support the hypothesis that the viability of hydrogen peroxide-stressed cells would increase with 
the pretreatment of ethynodiol diacetate. A previous study indicated that when progesterone was 
delivered to a patient after a brain injury, it caused a decrease in the cytotoxic responses as well 
as promoting functional recovery (Grossman, et al., 2004). Another study done by Cervantes et 
al., (2001) showed that progesterone played a role in the reduction of neuronal cell death. In my 
study, however, ethynodiol diacetate did not provide any protection to the glial cells against the 
hydrogen peroxide stressor. The concentrations used in this study, 0 uM, 0.01 uM, 0.1 pM, 1 pM 
and 10 uM, may have been too low to induce any protective effects towards the glial cells. 
Higher concentrations, though, would not be analogous to in vivo levels. For example, the in vivo 
blood concentration of ethynodiol diacetate from consuming oral hormonal contraceptives is 
0.31 uM. In addition to concentrations, the glial cells were not properly adhering to the wells and 
were removed during trials, thus possibly skewing the data as both live and dead cells were being 
removed. This observation could be indicative of the cells either being unhealthy prior to 
treatment or requiring a longer incubation time to adhere to the wells. 
One study showed that hydrogen peroxide alters astrocyte membrane and cytoskeleton 
through damaging lipids, proteins, DNA, and through signaling molecules which cause the 
intracellular pathways to cause apoptosis (Choi et al., 2007). The treatment of cells with 
16 
hydrogen peroxide appeared to causes a decrease in cell viability, but cannot be concluded 
without doing further tests to determine the oxidative stress caused by hydrogen peroxide to glial 
cells. Thus, future studies could look at directly measuring the oxidative stress hydrogen 
peroxide imposes on the cells. 
This study was limited to three trials due to time constraints and contamination to the 
glial cells. Data was limited when concerning the effects of progesterone on glial cell viability, 
due to most research being centered towards the effects progesterone has on reproductive 
functions and not how they affect glial cells. Therefore, it became difficult to determine adequate 
concentrations and exposure time for ethynodiol diacetate. Thus, it is possible that ethynodiol 
diacetate did not have enough time to exert effects on the glial cells. 
The ability to better understand the effects of ethynodiol diacetate, a main progesterone 
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